Latest news
25 items- 13D/GSEC Form SC 13G filed by Burcon NutraScience Corp.SC 13G - Burcon NutraScience Corp (0001158399) (Subject)
- SECSEC Form 6-K filed by Burcon NutraScience Corp.6-K - Burcon NutraScience Corp (0001158399) (Filer)
- SECSEC Form D filed by Burcon NutraScience Corp.D - Burcon NutraScience Corp (0001158399) (Filer)
- SECSEC Form 25 filed by Burcon NutraScience Corp.25 - Burcon NutraScience Corp (0001158399) (Filer)
- NEWSWhy Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From YesterdayGainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. IVERIC bio, Inc. (NASDAQ:ISEE) rose 66.3% to close at $15.70 on Tuesday after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA). HyreCar Inc. (NASDAQ:HYRE) climbed 58.1% to close at $1.27 on Tuesday after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners. Spero Therapeutics, Inc. (NASDAQ:SPRO) gained 55.5% to close at $1.13. Spero Therapeutics received minutes from a recent Type A meeting wi
- NEWSWhy HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day SessionGainers HyreCar Inc. (NASDAQ:HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners. ChannelAdvisor Corporation (NYSE:ECOM) shares climbed 54.9% to $22.77 after the company announced it will be acquired by CommerceHub for $23.10 per share IVERIC bio, Inc. (NASDAQ:ISEE) gained 41.4% to $13.35 after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA). Nutex Health, Inc. (NASDAQ:NUTX) rose 39% to $3.33. Nutex Health recently reported Q2 earnings results. Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:
- SECSEC Form 6-K filed by Burcon NutraScience Corp.6-K - Burcon NutraScience Corp (0001158399) (Filer)
- PRBurcon Issues Shareholder LetterVancouver, British Columbia--(Newsfile Corp. - September 6, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today issued a letter to shareholders from its Interim CEO and Chairman of the Board, Peter H. Kappel.Dear Fellow Shareholders,This past Friday we announced the resignation of our Auditor of the past 21 years, PricewaterhouseCoopers LLP ("PwC"). This must have come as a surprise to you, as it did us when we were informed by PwC their intention to resign. What was particularly agonizing for us was their insistence on the immediacy of carrying throu
- NEWSWhy DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving PremarketGainers First Wave BioPharma, Inc. (NASDAQ:FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday. Organovo Holdings, Inc. (NASDAQ:ONVO) rose 25.1% to $2.89 in pre-market trading. Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) shares rose 24% to $0.85 in pre-market trading after declining around 5% on Friday. Rubius Therapeutics, Inc. (NASDAQ:RUBY) rose 16.7% to $1.08 in pre-market trading after climbing over 23% on Friday. CytomX Therapeutics, Inc. (NASDAQ:CTMX) rose 15.1% to $1.68 in pre-market trading. CytomX Therapeutics, last month, posted a Q2 loss of $0.37 per share. GlycoMimetics, Inc. (NASDAQ:GLYC) rose 15% to $0.85 in pre-market trading. The company
- SECSEC Form 6-K filed by Burcon NutraScience Corp.6-K - Burcon NutraScience Corp (0001158399) (Filer)
- SECSEC Form 6-K filed by Burcon NutraScience Corp.6-K - Burcon NutraScience Corp (0001158399) (Filer)
- NEWSBurcon Announces Auditor Resignation, Postponement Of Annual Meeting Of ShareholdersBurcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today announced the resignation of its auditors, PricewaterhouseCoopers LLP ("PwC"), effective September 1, 2022 and that it is postponing its annual meeting of shareholders (the "AGM"), which was to be held on September 14, 2022. PwC has confirmed that there have been no "reportable events", "disagreements" or "unresolved issues" (as such terms are defined in National Instrument 51-102 - Continuous Disclosure Obligations). Due to the inopportune timing of PwC's notice of resignation, the Company's Board of Direct
- NEWSBurcon Announces Delisting from Nasdaq Capital Market On Or About September 12Vancouver, British Columbia--(Newsfile Corp. - September 2, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that it intends to file a Form 25 (Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934) with the Securities and Exchange Commission (the "SEC") on September 12, 2022 to delist the Company's common shares from the Nasdaq Capital Market and to deregister its common shares under Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The commo
- PRBurcon Announces Delisting from Nasdaq Capital MarketVancouver, British Columbia--(Newsfile Corp. - September 2, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today announced that it intends to file a Form 25 (Notification of Removal from Listing and/or Registration under Section 12(b) of the Securities Exchange Act of 1934) with the Securities and Exchange Commission (the "SEC") on September 12, 2022 to delist the Company's common shares from the Nasdaq Capital Market and to deregister its common shares under Section 12(b) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The comm
- PRBurcon Announces Auditor Resignation and AGM PostponementVancouver, British Columbia--(Newsfile Corp. - September 2, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, today announced the resignation of its auditors, PricewaterhouseCoopers LLP ("PwC"), effective September 1, 2022 and that it is postponing its annual meeting of shareholders (the "AGM"), which was to be held on September 14, 2022.PwC has confirmed that there have been no "reportable events", "disagreements" or "unresolved issues" (as such terms are defined in National Instrument 51-102 - Continuous Disclosure Obligations). Due to the inopportune tim
- SECSEC Form 6-K filed by Burcon NutraScience Corp.6-K - Burcon NutraScience Corp (0001158399) (Filer)
- SECSEC Form 6-K filed by Burcon NutraScience Corp.6-K - Burcon NutraScience Corp (0001158399) (Filer)
- NEWSBurcon NutraScience Q1 EPS $(0.04) Down From $(0.02) YoYBurcon NutraScience (NASDAQ:BRCN) reported quarterly losses of $(0.04) per share. This is a 100 percent decrease over losses of $(0.02) per share from the same period last year.
- PRBurcon Reports Fiscal 2023 First Quarter ResultsVancouver, British Columbia--(Newsfile Corp. - August 15, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, reported results for the fiscal first quarter ended June 30, 2022.Operational highlights for the first quarter ended June 30, 2022:During the quarter, Burcon:recorded a 17% quarter-over-quarter increase in royalty revenues from its licensee, Merit Functional Foods Corporation ("Merit");provided a $3.16 million loan to Merit, as part of a $10 million funding contributed by shareholders in proportion to their Merit shareholding;advanced the due diligence
- NEWSEarnings Scheduled For August 15, 2022Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter. • GreenPower Motor Co (NASDAQ:GP) is estimated to report quarterly loss at $0.15 per share on revenue of $5.59 million. • Mondee Hldgs (NASDAQ:MOND) is likely to report quarterly loss at $0.04 per share on revenue of $38.94 million. • Reshape Lifesciences (NASDAQ:RSLS) is expected to report quarterly loss at $0.35 per share on revenue of $3.41 million. • Alaunos Therapeutics (NASDAQ:TCRT) is expected to report earnings for its second quarter. • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $0.19 per share on revenue of $5.25 million. • IM Cannab
- SECSEC Form 6-K filed by Burcon NutraScience Corp.6-K - Burcon NutraScience Corp (0001158399) (Filer)
- PRBurcon Announces Fiscal 2023 First Quarter Conference Call to be Held on August 15, 2022Vancouver, British Columbia--(Newsfile Corp. - August 2, 2022) - Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BRCN) ("Burcon" or the "Company"), a global technology leader in the development of plant-based proteins for foods and beverages, will hold an investor conference call and webcast on Monday, August 15, 2022 at 5:00 p.m. Eastern time to discuss its financial results for the fiscal first quarter ended June 30, 2022. The Company's financial results will be issued in a press release prior to the call.A link to the webcast of the conference call will be available on Burcon's website under "Presentations" or directly here. The webcast will also be archived for future playback.Investo
- SECSEC Form 20-F filed by Burcon NutraScience Corp.20-F - Burcon NutraScience Corp (0001158399) (Filer)
- SECSEC Form 6-K filed by Burcon NutraScience Corp.6-K - Burcon NutraScience Corp (0001158399) (Filer)
- SECSEC Form 6-K filed by Burcon NutraScience Corp.6-K - Burcon NutraScience Corp (0001158399) (Filer)